Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer

Testing for her2/neu in breast cancer at the time of primary diagnosis is now the standard of care. Accurate and standardized testing methods are of prime importance to ensure the proper classification of the patient’s her2/neu status. A meeting of pathologists from across Canada was convened to upd...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, W., O’Malley, F.P., Barnes, P., Berendt, R., Gaboury, L., Magliocco, A., Pettigrew, N., Robertson, S., Sengupta, S., Têtu, B., Thomson, T.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2007
Materias:
Practice Guideline Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948868/
https://www.ncbi.nlm.nih.gov/pubmed/17710207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948868/
https://www.ncbi.nlm.nih.gov/pubmed/17710207

Ejemplares similares